Considerations for the Utility of the CPIC Guideline for CYP2D6 Genotype and Codeine Therapy

Simple item page
dc.contributor.authorCrews, Kristine R.
dc.contributor.authorCaudle, Kelly E.
dc.contributor.authorDunnenberger, Henry M.
dc.contributor.authorSadhasivam, Senthilkumar
dc.contributor.authorSkaar, Todd C.
dc.date.accessioned2022-10-10T17:57:38Z
dc.date.available2022-10-10T17:57:38Z
dc.date.issued2015-05
dc.identifier.citationKristine R Crews, Kelly E Caudle, Henry M Dunnenberger, Senthilkumar Sadhasivam, Todd C Skaar, Considerations for the Utility of the CPIC Guideline for CYP2D6 Genotype and Codeine Therapy, Clinical Chemistry, Volume 61, Issue 5, 1 May 2015, Pages 775–776, https://doi.org/10.1373/clinchem.2014.237412en_US
dc.identifier.urihttps://hdl.handle.net/1805/30301
dc.language.isoen_USen_US
dc.publisherOxford University Pressen_US
dc.relation.isversionof10.1373/clinchem.2014.237412en_US
dc.subjectGuidelinesen_US
dc.subjectClinical Pharmacogenetics Implementation Consortiumen_US
dc.subjectClinical high-throughputen_US
dc.subjectPreemptive genotypingen_US
dc.titleConsiderations for the Utility of the CPIC Guideline for CYP2D6 Genotype and Codeine Therapyen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Crews2015Considerations.pdf
Size:
62.62 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Todd Skaar
Open Access Policy Articles